Evidence map›Paper›PMID 35766325›Full record

ArticleObesity (Silver Spring, Md.)2022

Individuals with obesity who survive SARS-CoV-2 infection have preserved antigen-specific T cell frequencies.

Neil E Wrigley Kelly, Grace Kenny, Féaron C Cassidy, Alejandro A Garcia-Leon, Conor De Barra, Patrick W G Mallon, Andrew E Hogan, Donal O'Shea

Open access · hybridAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Neil E Wrigley KellySt Vincent's University Hospital & University College Dublin, Dublin, Ireland.
Grace KennySt Vincent's University Hospital & University College Dublin, Dublin, Ireland.
Féaron C CassidyKathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland.ORCID 0000-0003-2577-9519
Alejandro A Garcia-LeonCentre for Experimental Pathogen Host Research, School of Medicine, University College Dublin, Dublin, Ireland.
Conor De BarraKathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland.
Patrick W G MallonSt Vincent's University Hospital & University College Dublin, Dublin, Ireland.
Andrew E HoganKathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland.ORCID 0000-0001-5875-230X
Donal O'SheaSt Vincent's University Hospital & University College Dublin, Dublin, Ireland.
University College Dublin · IENational University of Ireland, Maynooth · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveObesity is a major risk factor for severe disease in COVID-19, with increased hospitalization, intensive care unit admission, and mortality. This increased impact of COVID-19 in people with obesity (PWO) is likely driven, in part, by the well-described obesity-induced immune dysregulation. Obesity has also been associated with impaired immune memory in many settings, including weakened responses to hepatitis B, tetanus, rabies, and influenza vaccination. Recently, it was reported that PWO who have COVID-19 have reduced IgG antibody titers with defective neutralizing capabilities. However, it remains unknown whether PWO generate durable T cell immunity to SARS-CoV-2.

methodsThis study investigated SARS-CoV-2-specific T cell responses in a cohort of 40 patients (n = 20 PWO and n = 20 matched control individuals) who had recovered from COVID-19. T cell (CD4

resultsCirculating T cells specific for SARS-CoV-2 were readily detected in the total cohort. PWO displayed comparable levels of SARS-CoV-2 spike- and membrane-specific T cells, with both T cell subsets responding.

conclusionsThese data indicate that PWO who survive COVID-19 generate robust and durable SARS-CoV-2-specific T cell immunity that is equivalent to that seen in those without obesity.

Indexed as

COVID-19CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHumansImmunoglobulin GImmunologic MemoryObesitySARS-CoV-2Tumor Necrosis Factor-alphaImmunoglobulin GTumor Necrosis Factor-alpha

Identifiers

PMID35766325
PMCPMC9350216
OpenAlexW4283736909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.